The GLOW blend is often marketed with strong claims. This page sets out what the published evidence actually looks like for each component, including how strong it is and what hasn’t been studied.
Evidence at a glance
| Compound | Main evidence type | Human data | Approved uses |
|---|---|---|---|
| GHK-Cu | Cell culture, animal wound models, gene-expression analyses; small topical cosmetic studies | Limited, mainly topical cosmetic | Cosmetic ingredient only |
| BPC-157 | Rodent injury and GI models, mostly from one research network | Very limited; no adequately powered trials published | None |
| TB-500 | Mostly extrapolated from full-length thymosin beta-4 research; anti-doping detection studies | None for the fragment | None |
| The GLOW combination | None published | None | None |
GHK-Cu
GHK-Cu has the deepest literature of the three. Reviews by Pickart and colleagues describe stimulation of collagen and glycosaminoglycan synthesis, faster wound closure in animal models, and broad effects on gene expression in computational analyses. Human evidence comes mainly from small studies of topical cosmetic products. Full GHK-Cu profile →
BPC-157
Many rodent studies report faster healing of tendon, ligament, muscle, skin and gastrointestinal injuries. A 2025 systematic review in orthopaedic sports medicine concluded that the evidence is overwhelmingly preclinical, and that human data is limited to very small reports. Independent replication outside the original research group is limited. Full BPC-157 profile →
TB-500
Most cited “TB-500 research” actually studies full-length thymosin beta-4, which has been linked to cell migration, angiogenesis and tissue repair in animal models and was taken into early clinical trials for some indications. Direct research on the seven-residue fragment is sparse. Full TB-500 profile →
The combination
We found no peer-reviewed study that tests GHK-Cu, BPC-157 and TB-500 together. The idea that they work well together is a hypothesis based on their separate mechanisms. It’s a reasonable question for research, but it isn’t an established finding.
How to read peptide research critically
- Model: cell, rodent or human? Results often don’t carry over from one to the next.
- Compound: was the fragment studied, or the parent protein?
- Replication: have independent groups reproduced the findings?
- Funding and authorship: are the authors connected to a commercial interest?
This summary is educational and may not include every study. It is not medical advice. None of these compounds is approved for human use. Last reviewed September 2026.